Company intelligence / Profile preview

Hypo-Stream

Oxford, Oxfordshire, United Kingdom

Ownership: Private
Development stage: Other

Overview

HypoStream was a medical technology company focused on developing innovative solutions for diabetes management, specifically targeting the detection and monitoring of hypoglycemia. The company's primary focus was the development of a non-invasive or minimally invasive glucose monitoring system designed to provide real-time alerts for low blood sugar levels. By leveraging advanced sensor technology, HypoStream aimed to improve the safety and quality of life for individuals living with insulin-dependent diabetes. Despite its promising technological approach, the company is no longer active and was dissolved in 2017.

Therapeutic areas: Endocrinology
Modalities: Device
Industry: Metabolite Diagnostics

Beyond the preview

Go deeper on Hypo-Stream.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hypo-Stream.

Explore the full profile